The Filings Report

Clorox Company

CLXNYSECIK 21076Consumer Defensive / Household & Personal Productsfiscal year ends June73 quarters since 2008

Revenue, Q1 FY2027
$1.9B
+33.3% on Q1 FY2026
Net income
$170M
+112.5% on Q1 FY2026
Free cash flow
$105M
+84.2% on Q1 FY2026
Diluted EPS
$1.39
+113.8% on Q1 FY2026
Revenue, TTM
—
trailing four quarters
Net margin, TTM
—
net income —
Free cash flow, TTM
—
Cash and equivalents
$184M
long-term debt $4.0B, Sep 30, 2026
Shares, 12-month change
−0.7%
121M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$12.1B
at the close, buybacks

Latest quarter Q1 FY2027, filed November 2, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q1 FY2027, the quarter ended September 30, 2026, Clorox Company reported revenue of $1.9B, +33.3% on Q1 FY2026, and net income of $170M (+112.5%). Free cash flow, operating cash flow less capital expenditures, was $105M ($143M less $38M). Diluted earnings per share were $1.39.

Share price

Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

CLX daily priceSplit-adjusted, US dollars; an earnings release
Nov 6, 2026O $96.74 · H $100.54 · L $96.19 · C $99.96 · +0.26% on the dayOver the range: −5.95%, Nov 7, 2025 to Nov 6, 2026
$76$90$104$118$132Nov 25Jan 26Apr 26Jun 26Aug 26Nov 26

The last 16 quarters

Q2 FY2023 to Q1 FY2027, through the filing of November 2, 2026.

Revenue and net incomeRevenueNet income
−$1B$0$1B$2B$3BQ2'23, Revenue: $1.7BQ2'23, Net income: $99MQ2'23Q3'23, Revenue: $1.9BQ3'23, Net income: −$211MQ3'23Q4'23, Revenue: $2.0BQ4'23, Net income: $176MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $22MQ1'24Q2'24, Revenue: $2.0BQ2'24, Net income: $93MQ2'24Q3'24, Revenue: $1.8BQ3'24, Net income: −$51MQ3'24Q4'24, Revenue: $1.9BQ4'24, Net income: $216MQ4'24Q1'25, Revenue: $1.8BQ1'25, Net income: $99MQ1'25Q2'25, Revenue: $1.7BQ2'25, Net income: $193MQ2'25Q3'25, Revenue: $1.7BQ3'25, Net income: $186MQ3'25Q4'25, Revenue: $2.0BQ4'25, Net income: $332MQ4'25Q1'26, Revenue: $1.4BQ1'26, Net income: $80MQ1'26Q2'26, Revenue: $1.7BQ2'26, Net income: $157MQ2'26Q3'26, Revenue: $1.7BQ3'26, Net income: $187MQ3'26Q4'26Q1'27, Revenue: $1.9BQ1'27, Net income: $170MQ1'27−$1B$0$1B$2B$3BQ2'23, Revenue: $1.7BQ2'23, Net income: $99MQ2'23Q3'23, Revenue: $1.9BQ3'23, Net income: −$211MQ3'23Q4'23, Revenue: $2.0BQ4'23, Net income: $176MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $22MQ1'24Q2'24, Revenue: $2.0BQ2'24, Net income: $93MQ2'24Q3'24, Revenue: $1.8BQ3'24, Net income: −$51MQ3'24Q4'24, Revenue: $1.9BQ4'24, Net income: $216MQ4'24Q1'25, Revenue: $1.8BQ1'25, Net income: $99MQ1'25Q2'25, Revenue: $1.7BQ2'25, Net income: $193MQ2'25Q3'25, Revenue: $1.7BQ3'25, Net income: $186MQ3'25Q4'25, Revenue: $2.0BQ4'25, Net income: $332MQ4'25Q1'26, Revenue: $1.4BQ1'26, Net income: $80MQ1'26Q2'26, Revenue: $1.7BQ2'26, Net income: $157MQ2'26Q3'26, Revenue: $1.7BQ3'26, Net income: $187MQ3'26Q4'26Q1'27, Revenue: $1.9BQ1'27, Net income: $170MQ1'27−$1B$0$1B$2B$3BQ2'23, Revenue: $1.7BQ2'23, Net income: $99MQ3'23, Revenue: $1.9BQ3'23, Net income: −$211MQ3'23Q4'23, Revenue: $2.0BQ4'23, Net income: $176MQ1'24, Revenue: $1.4BQ1'24, Net income: $22MQ1'24Q2'24, Revenue: $2.0BQ2'24, Net income: $93MQ3'24, Revenue: $1.8BQ3'24, Net income: −$51MQ3'24Q4'24, Revenue: $1.9BQ4'24, Net income: $216MQ1'25, Revenue: $1.8BQ1'25, Net income: $99MQ1'25Q2'25, Revenue: $1.7BQ2'25, Net income: $193MQ3'25, Revenue: $1.7BQ3'25, Net income: $186MQ3'25Q4'25, Revenue: $2.0BQ4'25, Net income: $332MQ1'26, Revenue: $1.4BQ1'26, Net income: $80MQ1'26Q2'26, Revenue: $1.7BQ2'26, Net income: $157MQ3'26, Revenue: $1.7BQ3'26, Net income: $187MQ3'26Q1'27, Revenue: $1.9BQ1'27, Net income: $170MQ1'27

Net income losses drawn in red.

Free cash flow
−$200M$0$200M$400MQ2'23, Free cash flow: $167MQ2'23Q3'23, Free cash flow: $285MQ3'23Q4'23, Free cash flow: $346MQ4'23Q1'24, Free cash flow: −$4MQ1'24Q2'24, Free cash flow: $101MQ2'24Q3'24, Free cash flow: $127MQ3'24Q4'24, Free cash flow: $259MQ4'24Q1'25, Free cash flow: $182MQ1'25Q2'25, Free cash flow: $127MQ2'25Q3'25, Free cash flow: $233MQ3'25Q4'25, Free cash flow: $219MQ4'25Q1'26, Free cash flow: $57MQ1'26Q2'26, Free cash flow: $269MQ2'26Q3'26, Free cash flow: −$165MQ3'26Q4'26Q1'27, Free cash flow: $105MQ1'27−$200M$0$200M$400MQ2'23, Free cash flow: $167MQ2'23Q3'23, Free cash flow: $285MQ3'23Q4'23, Free cash flow: $346MQ4'23Q1'24, Free cash flow: −$4MQ1'24Q2'24, Free cash flow: $101MQ2'24Q3'24, Free cash flow: $127MQ3'24Q4'24, Free cash flow: $259MQ4'24Q1'25, Free cash flow: $182MQ1'25Q2'25, Free cash flow: $127MQ2'25Q3'25, Free cash flow: $233MQ3'25Q4'25, Free cash flow: $219MQ4'25Q1'26, Free cash flow: $57MQ1'26Q2'26, Free cash flow: $269MQ2'26Q3'26, Free cash flow: −$165MQ3'26Q4'26Q1'27, Free cash flow: $105MQ1'27−$200M$0$200M$400MQ2'23, Free cash flow: $167MQ3'23, Free cash flow: $285MQ3'23Q4'23, Free cash flow: $346MQ1'24, Free cash flow: −$4MQ1'24Q2'24, Free cash flow: $101MQ3'24, Free cash flow: $127MQ3'24Q4'24, Free cash flow: $259MQ1'25, Free cash flow: $182MQ1'25Q2'25, Free cash flow: $127MQ3'25, Free cash flow: $233MQ3'25Q4'25, Free cash flow: $219MQ1'26, Free cash flow: $57MQ1'26Q2'26, Free cash flow: $269MQ3'26, Free cash flow: −$165MQ3'26Q1'27, Free cash flow: $105MQ1'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3B$4BQ2'23, Cash and equivalents: $168MQ2'23, Long-term debt: $2.5BQ2'23Q3'23, Cash and equivalents: $242MQ3'23, Long-term debt: $2.5BQ3'23Q4'23, Cash and equivalents: $367MQ4'23, Long-term debt: $2.5BQ4'23Q1'24, Cash and equivalents: $518MQ1'24, Long-term debt: $2.5BQ1'24Q2'24, Cash and equivalents: $355MQ2'24, Long-term debt: $2.5BQ2'24Q3'24, Cash and equivalents: $219MQ3'24, Long-term debt: $2.5BQ3'24Q4'24, Cash and equivalents: $202MQ4'24, Long-term debt: $2.5BQ4'24Q1'25, Cash and equivalents: $278MQ1'25, Long-term debt: $2.5BQ1'25Q2'25, Cash and equivalents: $290MQ2'25, Long-term debt: $2.5BQ2'25Q3'25, Cash and equivalents: $226MQ3'25, Long-term debt: $2.5BQ3'25Q4'25, Cash and equivalents: $167MQ4'25, Long-term debt: $2.5BQ4'25Q1'26, Cash and equivalents: $166MQ1'26, Long-term debt: $2.5BQ1'26Q2'26, Cash and equivalents: $227MQ2'26, Long-term debt: $2.5BQ2'26Q3'26, Cash and equivalents: $1.2BQ3'26, Long-term debt: $2.5BQ3'26Q4'26, Cash and equivalents: $143MQ4'26, Long-term debt: $4.0BQ4'26Q1'27, Cash and equivalents: $184MQ1'27, Long-term debt: $4.0BQ1'27$0$1B$2B$3B$4BQ2'23, Cash and equivalents: $168MQ2'23, Long-term debt: $2.5BQ2'23Q3'23, Cash and equivalents: $242MQ3'23, Long-term debt: $2.5BQ3'23Q4'23, Cash and equivalents: $367MQ4'23, Long-term debt: $2.5BQ4'23Q1'24, Cash and equivalents: $518MQ1'24, Long-term debt: $2.5BQ1'24Q2'24, Cash and equivalents: $355MQ2'24, Long-term debt: $2.5BQ2'24Q3'24, Cash and equivalents: $219MQ3'24, Long-term debt: $2.5BQ3'24Q4'24, Cash and equivalents: $202MQ4'24, Long-term debt: $2.5BQ4'24Q1'25, Cash and equivalents: $278MQ1'25, Long-term debt: $2.5BQ1'25Q2'25, Cash and equivalents: $290MQ2'25, Long-term debt: $2.5BQ2'25Q3'25, Cash and equivalents: $226MQ3'25, Long-term debt: $2.5BQ3'25Q4'25, Cash and equivalents: $167MQ4'25, Long-term debt: $2.5BQ4'25Q1'26, Cash and equivalents: $166MQ1'26, Long-term debt: $2.5BQ1'26Q2'26, Cash and equivalents: $227MQ2'26, Long-term debt: $2.5BQ2'26Q3'26, Cash and equivalents: $1.2BQ3'26, Long-term debt: $2.5BQ3'26Q4'26, Cash and equivalents: $143MQ4'26, Long-term debt: $4.0BQ4'26Q1'27, Cash and equivalents: $184MQ1'27, Long-term debt: $4.0BQ1'27$0$1B$2B$3B$4BQ2'23, Cash and equivalents: $168MQ2'23, Long-term debt: $2.5BQ3'23, Cash and equivalents: $242MQ3'23, Long-term debt: $2.5BQ3'23Q4'23, Cash and equivalents: $367MQ4'23, Long-term debt: $2.5BQ1'24, Cash and equivalents: $518MQ1'24, Long-term debt: $2.5BQ1'24Q2'24, Cash and equivalents: $355MQ2'24, Long-term debt: $2.5BQ3'24, Cash and equivalents: $219MQ3'24, Long-term debt: $2.5BQ3'24Q4'24, Cash and equivalents: $202MQ4'24, Long-term debt: $2.5BQ1'25, Cash and equivalents: $278MQ1'25, Long-term debt: $2.5BQ1'25Q2'25, Cash and equivalents: $290MQ2'25, Long-term debt: $2.5BQ3'25, Cash and equivalents: $226MQ3'25, Long-term debt: $2.5BQ3'25Q4'25, Cash and equivalents: $167MQ4'25, Long-term debt: $2.5BQ1'26, Cash and equivalents: $166MQ1'26, Long-term debt: $2.5BQ1'26Q2'26, Cash and equivalents: $227MQ2'26, Long-term debt: $2.5BQ3'26, Cash and equivalents: $1.2BQ3'26, Long-term debt: $2.5BQ3'26Q4'26, Cash and equivalents: $143MQ4'26, Long-term debt: $4.0BQ1'27, Cash and equivalents: $184MQ1'27, Long-term debt: $4.0BQ1'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q1 FY2027 filed November 2, 2026.

Clorox Company income statement, quarterly
Millions of dollarsQ1 FY2027ended Sep 30, 2026filed Nov 2, 2026Q4 FY2026ended Jun 30, 2026filed Nov 2, 2026Q3 FY2026ended Mar 31, 2026filed Apr 30, 2026Q2 FY2026ended Dec 31, 2025filed Feb 3, 2026Q1 FY2026ended Sep 30, 2025filed Nov 3, 2025Q4 FY2025ended Jun 30, 2025filed Aug 8, 2025Q3 FY2025ended Mar 31, 2025filed May 5, 2025Q2 FY2025ended Dec 31, 2024filed Feb 3, 2025YoYQ1 FY2027vs Q1 FY2026
Revenue1,905—1,6701,6731,4291,9881,6681,686+33.3%
Cost of revenue1,135—9489518331,064924948+36.3%
Gross profit770—722722596924744738+29.2%
Research and development29—272928322731+3.6%
Selling, general and administrative290—229262277296267280+4.7%
Operating income—————————
Other income (expense)—————————
Pretax income207—256215107410254237+93.5%
Income tax34—655425746343+36.0%
Net income170—18715780332186193+112.5%
Diluted EPS ($)1.39—1.541.290.65—1.501.54+113.8%
Diluted shares (millions)122—122122123—124125—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q1 FY2027 filed November 2, 2026.

Clorox Company balance sheet, quarterly
Millions of dollarsQ1 FY2027ended Sep 30, 2026filed Nov 2, 2026Q4 FY2026ended Jun 30, 2026filed Nov 2, 2026Q3 FY2026ended Mar 31, 2026filed Apr 30, 2026Q2 FY2026ended Dec 31, 2025filed Feb 3, 2026Q1 FY2026ended Sep 30, 2025filed Nov 3, 2025Q4 FY2025ended Jun 30, 2025filed Aug 8, 2025Q3 FY2025ended Mar 31, 2025filed May 5, 2025Q2 FY2025ended Dec 31, 2024filed Feb 3, 2025YoYQ1 FY2027vs Q1 FY2026
Cash and equivalents1841431,187227166167226290+10.8%
Short-term investments—————————
Total current assets1,9311,8242,6511,7281,6951,6081,5901,632+13.9%
Total assets7,8327,7946,4365,6135,5285,5615,5125,577+41.7%
Total current liabilities2,9542,7733,1552,3472,2341,9192,1551,730+32.2%
Long-term debt3,9823,9812,4872,4862,4852,4842,4832,483+60.2%
Total liabilities7,7117,5426,3445,5785,3905,0795,3225,456+43.1%
Stockholders’ equity(39)90(67)(125)(22)32127(41)−77.3%
Shares outstanding (millions)121121121121122122123123—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q1 FY2027 filed November 2, 2026.

Clorox Company cash flow statement, quarterly
Millions of dollarsQ1 FY2027ended Sep 30, 2026filed Nov 2, 2026Q4 FY2026ended Jun 30, 2026filed Nov 2, 2026Q3 FY2026ended Mar 31, 2026filed Apr 30, 2026Q2 FY2026ended Dec 31, 2025filed Feb 3, 2026Q1 FY2026ended Sep 30, 2025filed Nov 3, 2025Q4 FY2025ended Jun 30, 2025filed Aug 8, 2025Q3 FY2025ended Mar 31, 2025filed May 5, 2025Q2 FY2025ended Dec 31, 2024filed Feb 3, 2025YoYQ1 FY2027vs Q1 FY2026
Operating cash flow143—(122)31193294286180+53.8%
Capital expenditures38—434236755353+5.6%
Free cash flow (CFO − capex)105—(165)26957219233127+84.2%
Depreciation and amortization74—585556575553+32.1%
Share repurchases0—0127129750150−100.0%
Dividends paid151—1501511511501501510.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed November 2, 2026.

Income statement

Clorox Company income statement, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Nov 2, 2026FY2025ended Jun 30, 2025filed Aug 8, 2025FY2024ended Jun 30, 2024filed Aug 8, 2024FY2023ended Jun 30, 2023filed Aug 10, 2023FY2022ended Jun 30, 2022filed Aug 10, 2022FY2021ended Jun 30, 2021filed Aug 10, 2021FY2020ended Jun 30, 2020filed Aug 13, 2020FY2019ended Jun 30, 2019filed Aug 14, 2019FY2018ended Jun 30, 2018filed Aug 14, 2018FY2017ended Jun 30, 2017filed Aug 15, 2017FY2016ended Jun 30, 2016filed Aug 16, 2016FY2015ended Jun 30, 2015filed Aug 21, 2015FY2014ended Jun 30, 2014filed Aug 25, 2014FY2013ended Jun 30, 2013filed Aug 23, 2013FY2012ended Jun 30, 2012filed Aug 24, 2012FY2011ended Jun 30, 2011filed Aug 26, 2011FY2010ended Jun 30, 2010filed Aug 26, 2010FY2009ended Jun 30, 2009filed Nov 3, 2009FY2008ended Jun 30, 2008filed Nov 3, 2009
Revenue—7,1047,0937,3897,1077,3416,7216,2146,1245,9735,7615,6555,5145,5335,4685,2315,234——
Cost of revenue—3,8914,0454,4814,5624,1423,6583,4863,4493,3023,163————————
Gross profit—3,2133,0482,9082,5453,1993,0632,7282,6752,6712,5982,4652,3562,3912,3042,2732,3192,2042,175
Research and development—121126138132149145136132135141136125130121115118113111
Selling, general and administrative—1,1241,1671,1839541,004969856837810806798751793798735734703690
Operating income———————————————————
Other income (expense)——————————713104132329——
Pretax income—1,0783982386079001,1851,0241,0541,033983921884——————
Income tax—25410677136181246204231330335315305279248276322274232
Net income—810280149462710939820823701648580558572541557603537461
Diluted EPS ($)—6.522.251.203.735.587.366.326.265.334.924.374.234.304.094.024.243.793.23
Diluted shares (millions)—124125124124127128130132132132133132133132138142140141

Balance sheet

Clorox Company balance sheet, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Nov 2, 2026FY2025ended Jun 30, 2025filed Aug 8, 2025FY2024ended Jun 30, 2024filed Aug 8, 2024FY2023ended Jun 30, 2023filed Aug 10, 2023FY2022ended Jun 30, 2022filed Aug 10, 2022FY2021ended Jun 30, 2021filed Aug 10, 2021FY2020ended Jun 30, 2020filed Aug 13, 2020FY2019ended Jun 30, 2019filed Aug 14, 2019FY2018ended Jun 30, 2018filed Aug 14, 2018FY2017ended Jun 30, 2017filed Aug 15, 2017FY2016ended Jun 30, 2016filed Aug 16, 2016FY2015ended Jun 30, 2015filed Aug 21, 2015FY2014ended Jun 30, 2014filed Aug 25, 2014FY2013ended Jun 30, 2013filed Aug 23, 2013FY2012ended Jun 30, 2012filed Aug 24, 2012FY2011ended Jun 30, 2011filed Aug 26, 2011FY2010ended Jun 30, 2010filed Aug 26, 2010FY2009ended Jun 30, 2009filed Nov 3, 2009FY2008ended Jun 30, 2008filed Nov 3, 2009
Cash and equivalents14316720236718331987111113141840138232929926725987206214
Short-term investments———————————————————
Total current assets1,8241,6081,6221,8281,7251,8292,0201,3051,3111,5141,4851,4291,3951,4201,3761,2791,4891,180—
Total assets7,7945,5615,7515,9456,1586,3346,2135,1165,0604,5734,5104,1544,2514,3024,3554,1634,5484,576—
Total current liabilities2,7731,9191,5741,9171,7842,0561,4181,4401,2001,8091,5581,4051,6381,1342,0611,3651,6451,937—
Long-term debt3,9812,4842,4812,4772,4742,4842,7802,2872,2841,3911,7891,7861,5882,1611,5712,1252,1242,151—
Total liabilities7,5425,0795,2595,5575,4295,7425,3054,5574,3344,0314,2134,0464,1044,1654,4904,2494,4654,751—
Stockholders’ equity90321328220556411908559726542297118154146(135)(86)83(175)—
Shares outstanding (millions)121122124124123123126126128129129129129130130131139140—

Cash flow statement

Clorox Company cash flow statement, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Nov 2, 2026FY2025ended Jun 30, 2025filed Aug 8, 2025FY2024ended Jun 30, 2024filed Aug 8, 2024FY2023ended Jun 30, 2023filed Aug 10, 2023FY2022ended Jun 30, 2022filed Aug 10, 2022FY2021ended Jun 30, 2021filed Aug 10, 2021FY2020ended Jun 30, 2020filed Aug 13, 2020FY2019ended Jun 30, 2019filed Aug 14, 2019FY2018ended Jun 30, 2018filed Aug 14, 2018FY2017ended Jun 30, 2017filed Aug 15, 2017FY2016ended Jun 30, 2016filed Aug 16, 2016FY2015ended Jun 30, 2015filed Aug 21, 2015FY2014ended Jun 30, 2014filed Aug 25, 2014FY2013ended Jun 30, 2013filed Aug 23, 2013FY2012ended Jun 30, 2012filed Aug 24, 2012FY2011ended Jun 30, 2011filed Aug 26, 2011FY2010ended Jun 30, 2010filed Aug 26, 2010FY2009ended Jun 30, 2009filed Nov 3, 2009FY2008ended Jun 30, 2008filed Nov 3, 2009
Operating cash flow—9816951,1587861,2761,546992976865778874767775612698819738730
Capital expenditures—220212228251331254206194231172125137190192228201196170
Free cash flow (CFO − capex)—7614839305359451,292786782634606749630585420470618542560
Depreciation and amortization—219235236224211180180166163165169177180178173183188205
Share repurchases—3320025905248661271183254434260128225655150—868
Dividends paid—602595583571558533490450412398385368335315303282258228

Insider activity

Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$400K
1 purchases by 1 insider; officers and directors $400K
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$1M
3 purchases by 1 insider; officers and directors $1M
Sold, twelve months
$0
0 sales by 0 insiders; officers and directors $0

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 4, 2026Breber Pierre RDirectoropen-market buyindirect4,000$100.06$400K22,000Nov 5, 2026
Oct 5, 2026Rendle Linda JChief Executive Officer, Directoraward29,352$80.41$2M282,488Oct 7, 2026
Oct 5, 2026Rendle Linda JChief Executive Officer, Directortax withholding692$80.41$56K281,796Oct 7, 2026
Oct 5, 2026Rendle Linda JChief Executive Officer, Directortax withholding11,989$80.41$964K269,807Oct 7, 2026
Oct 5, 2026Peck Laurene EVP - CAO & Corp Controlleraward1,172$80.41$94K10,386Oct 7, 2026
Oct 5, 2026Peck Laurene EVP - CAO & Corp Controllertax withholding30$80.41$2K10,356Oct 7, 2026
Oct 5, 2026Peck Laurene EVP - CAO & Corp Controllertax withholding339$80.41$27K10,017Oct 7, 2026
Oct 5, 2026Marriner KirstenEVP - Chief Admin Officeraward6,637$80.41$534K83,591Oct 7, 2026
Oct 5, 2026Marriner KirstenEVP - Chief Admin Officertax withholding1,951$80.41$157K81,640Oct 7, 2026
Oct 5, 2026Marriner KirstenEVP - Chief Admin Officertax withholding2,142$80.41$172K79,498Oct 7, 2026
Oct 5, 2026Hyder Chris TEVP-Chief Operating Officeraward4,191$80.41$337K94,618Oct 7, 2026
Oct 5, 2026Hyder Chris TEVP-Chief Operating Officertax withholding100$80.41$8K94,518Oct 7, 2026
Oct 5, 2026Hyder Chris TEVP-Chief Operating Officertax withholding1,532$80.41$123K92,986Oct 7, 2026
Oct 5, 2026Hilt Angela CEVP - Chief Legal Officeraward6,637$80.41$534K74,414Oct 7, 2026
Oct 5, 2026Hilt Angela CEVP - Chief Legal Officertax withholding2,296$80.41$185K72,118Oct 7, 2026
Oct 5, 2026Hilt Angela CEVP - Chief Legal Officertax withholding2,351$80.41$189K69,767Oct 7, 2026
Oct 5, 2026Bellet LucEVP - Chief Financial Officeraward1,677$80.41$135K76,471Oct 7, 2026
Oct 5, 2026Bellet LucEVP - Chief Financial Officertax withholding580$80.41$47K75,891Oct 7, 2026
Oct 5, 2026Bellet LucEVP - Chief Financial Officertax withholding1,031$80.41$83K74,860Oct 7, 2026
Oct 5, 2026Barton NinaEVP-Chief Growth & Strategy Oftax withholding1,106$80.41$89K36,179Oct 7, 2026
Sep 23, 2026Peck Laurene EVP - CAO & Corp Controlleraward2,192$83.94$184K9,160Sep 25, 2026
Sep 23, 2026Marriner KirstenEVP - Chief Admin Officeraward12,389$83.94$1M76,683Sep 25, 2026
Sep 23, 2026Hyder Chris TEVP-Chief Operating Officeraward13,342$83.94$1M90,202Sep 25, 2026
Sep 23, 2026Bellet LucEVP - Chief Financial Officeraward11,913$83.94$1000K74,669Sep 25, 2026
Sep 23, 2026Rendle Linda JChief Executive Officer, Directoraward50,988$83.94$4M252,149Sep 25, 2026

Full insider history for Clorox Company, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held CLX in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded CLX by quarter.

FundManagerQuarterValueSharesWeightMove
FundsmithTerry SmithQ2 2026$26M271,3180.19%added +5.5%

Sources

Fiscal year ends in month 6; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
THE CLOROX COMPANY, CIK 21076 on EDGAR
Extract generated
November 8, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: not filed
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 8, 2026.

JSON file
/data/financials/CLX.json